About FDA

General E-mail Questions to ONDQA

You may send questions to ONDQA using the following e-mail address: newdrugcmc@fda.hhs.gov. This e-mail account is intended to be used for external stakeholders asking general CMC or biopharmaceutics questions or requesting guidance on general matters that affect multiple applications or issues that cross ONDQA organization units. It should not be used for single product/application specific questions. Single product/application specific questions should not be sent through this e-mail account, but instead must go through the appropriate ONDQA Regulatory Project Manager.

Page Last Updated: 12/23/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English